Newron Pharmaceuticals SpA
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy. Show More...
-
Website https://www.newron.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 7.32 CHF
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR -3.11 -0.89 -0.29 -0.62 -0.8 -1.66 -1.04 -0.32 -0.84 -1.13 -1.13 Dividends EUR Payout Ratio % * Shares Mil 7.0 7.0 8.0 12.0 13.0 14.0 15.0 16.0 18.0 18.0 18.0 Book Value Per Share * CHF 2.94 1.96 1.37 2.69 3.17 3.59 2.21 3.44 3.86 2.56 2.2 Free Cash Flow Per Share * CHF -4.54 -1.38 0.28 -1.04 -0.79 -0.89 -1.29 -0.9 -1.04 -1.31 Return on Assets % -67.57 -39.42 -8.16 -18.61 -29.39 -56.02 -30.18 -8.15 -22.65 -33.67 -33.67 Financial Leverage (Average) 1.57 2.06 1.62 1.5 1.26 1.2 1.14 1.08 1.09 1.64 1.64 Return on Equity % -99.07 -68.65 -13.89 -29.15 -40.1 -68.75 -35.08 -8.99 -24.53 -44.1 -44.1 Return on Invested Capital % -98.41 -57.12 -12.79 -27.33 -38.18 -66.92 -34.82 -9.17 -24.63 -31.76 -31.76 Interest Coverage -155.06 -114.18 -61.36 -267.2 -34.25 -34.25 Current Ratio 2.83 2.7 2.83 3.59 6.55 6.75 8.45 15.4 13.9 10.71 10.71 Quick Ratio 2.74 2.61 2.7 3.4 6.41 6.52 8.24 14.98 10.57 7.38 7.38 Debt/Equity 0.27 0.05 0.05 0.02 0.010 0.46 0.46